“Oral Lipid Formulation Type IV As an Approach in the Formulation of Solid Dosage Forms With Poorly Soluble Substances: Chremophor®RH 40 As a Surfactant Phase”. Progress in Nutrition 23, no. 3 (October 7, 2021): e2021279. Accessed June 30, 2024. https://mattioli1885journals.com/index.php/progressinnutrition/article/view/12071.